Activan is prescribed for anxiety disorders, and Pacitane is used in treating Parkinson’s disease and other neurological ...

Glenmark Pharmaceuticals's US arm has launched a generic version of Clindamycin Phosphate foam, an antibiotic acne treatment.

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

Glenmark Pharmaceuticals has announced the launch of Clindamycin Phosphate Foam, which is a bioequivalent and therapeutically equivalent to the reference listed drug, Evoclin Foam of Mylan ...

Glenmark Pharmaceuticals Ltd on Wednesday said its US arm has launched the generic version of Clindamycin Phosphate foam, an.

According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million ...

This new product is bioequivalent and therapeutically equivalent to the reference-listed drug, Evoclin Foam, 1%, manufactured ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of clindamycin phosphate foam, 1%. Glenmark’s clindamycin phosphate foam, 1% is bioequivalent and therapeutically equivalent to the ...

Hillary Clinton has criticised Mylan for "exorbitant" price rises for one of its medicines, and highlighted a plan to reform drug pricing should she become US president in November. In a Facebook ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Unfortunately, the drug was denied a follow-on approval to ... In October last year, Mylan settled a patent dispute with Novo Nordisk, that advances the possibility of Viatris being able to ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...